CLINICAL_TRIALS
withdrawal
· 2025-12-17
Clinical Trial Update: VE202 in Patients With Mild-to-Moderate Ulcerative Colitis [Phase 2]
Summary
A Phase 2 trial of VE202 in Ulcerative Colitis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vedanta Biosciences, Inc. | Conditions: Ulcerative Colitis, Colitis, Ulcerative | Phase 2 | Status: TERMINATED